LLY's Zepbound to treat Sleep Apnea, QCOM Tops ARM in Court, Honda/Nissan Merger Talks
Description
Obesity drugmaker Eli Lilly (LLY) rises after Zepbound gets FDA approval for sleep apnea treatment. Meanwhile, Honda (HMC) and Nissan (NSANY) have begun merger discussions to potentially become the world's 3rd largest automaker. And, Qualcomm (QCOM) prevails in a legal dispute over Arm Holdings (ARM). George Tsilis provides insight on the morning's early headlines.
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe
Download the iOS app - https://apps.apple.com/us/app/schwab-...
Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-...
Watch on Sling - https://watch.sling.com/1/asset/19192...
Watch on Vizio - https://www.vizio.com/en/watchfreeplu...
Watch on DistroTV - https://www.distro.tv/live/schwab-net...
Follow us on X – / schwabnetwork
Follow us on Facebook – / schwabnetwork
Follow us on LinkedIn - / schwab-network
About Schwab Network - https://schwabnetwork.com/about